{"id":"W2018591383","doi":"10.1182/blood-2007-04-084293","title":"Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Idarubicin; Cytarabine; Fludarabine; Medicine; Internal medicine; Transplantation; Randomized controlled trial; Oncology; Leukemia; Surgery; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002251164,0.0005902315,0.0005795101,0.0003374937,0.0003622238,0.0006025034,0.0004135252,0.0007172443,0.0007234459],"category_scores_gemma":[0.001767928,0.0001472655,0.0007170926,0.0005181076,0.0004479435,0.0003348693,0.000371645,0.001467147,0.0001513666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001326626,"about_ca_system_score_gemma":0.001486244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002927046,"about_ca_topic_score_gemma":0.006378839,"domain_scores_codex":[0.9992115,0.0004670215,0.00003450785,0.00007725402,0.0001272869,0.00008227915],"domain_scores_gemma":[0.9984437,0.0001908828,0.0005769563,0.00009375287,0.00006356912,0.0006312626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4450782,0.01742032,0.2269707,0.001435561,0.002663275,0.001278336,0.000784145,0.0123098,0.02072694,0.001770096,0.02990532,0.2396573],"study_design_scores_gemma":[0.3194861,0.2117067,0.4324981,0.000385278,0.00185545,0.001879882,0.0001733239,0.003464428,0.006776846,0.001004498,0.02064909,0.0001203124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922192,0.003059773,0.0002020258,0.0006177124,0.00007555253,0.0005455519,0.002154674,0.00001788142,0.00110771],"genre_scores_gemma":[0.9865054,0.001887998,0.001434415,0.001076245,0.0001109805,0.001086917,0.006866554,0.00001938022,0.001012097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002927046,"threshold_uncertainty_score":0.01190543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01891023400183138,"score_gpt":0.3422142945803145,"score_spread":0.3233040605784831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}